Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 4
2007 3
2008 5
2009 2
2010 8
2011 4
2012 3
2013 9
2014 5
2015 4
2016 5
2017 7
2018 6
2019 14
2020 20
2021 11
2022 4
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Le Gouill S, Morschhauser F, Chiron D, Bouabdallah K, Cartron G, Casasnovas O, Bodet-Milin C, Ragot S, Bossard C, Nadal N, Herbaux C, Tessoulin B, Tchernonog E, Rossi C, McCulloch R, Gastinne T, Callanan MB, Rule S. Le Gouill S, et al. Among authors: bodet milin c. Blood. 2021 Feb 18;137(7):877-887. doi: 10.1182/blood.2020008727. Blood. 2021. PMID: 33181832 Free article. Clinical Trial.
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
Vercellino L, Di Blasi R, Kanoun S, Tessoulin B, Rossi C, D'Aveni-Piney M, Obéric L, Bodet-Milin C, Bories P, Olivier P, Lafon I, Berriolo-Riedinger A, Galli E, Bernard S, Rubio MT, Bossard C, Meignin V, Merlet P, Feugier P, Le Gouill S, Ysebaert L, Casasnovas O, Meignan M, Chevret S, Thieblemont C. Vercellino L, et al. Among authors: bodet milin c. Blood Adv. 2020 Nov 24;4(22):5607-5615. doi: 10.1182/bloodadvances.2020003001. Blood Adv. 2020. PMID: 33180899 Free PMC article.
[18F]-Fludarabine for Hematological Malignancies.
Barré L, Hovhannisyan N, Bodet-Milin C, Kraeber-Bodéré F, Damaj G. Barré L, et al. Among authors: bodet milin c. Front Med (Lausanne). 2019 Apr 17;6:77. doi: 10.3389/fmed.2019.00077. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31058154 Free PMC article. Review.
Immuno-PET: Design options and clinical proof-of-concept.
Lugat A, Bailly C, Chérel M, Rousseau C, Kraeber-Bodéré F, Bodet-Milin C, Bourgeois M. Lugat A, et al. Among authors: bodet milin c. Front Med (Lausanne). 2022 Oct 14;9:1026083. doi: 10.3389/fmed.2022.1026083. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314010 Free PMC article. Review.
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update.
Cicone F, Santo G, Bodet-Milin C, Cascini GL, Kraeber-Bodéré F, Stokke C, Kolstad A. Cicone F, et al. Among authors: bodet milin c. Semin Nucl Med. 2023 May;53(3):413-425. doi: 10.1053/j.semnuclmed.2022.12.006. Epub 2023 Jan 10. Semin Nucl Med. 2023. PMID: 36635112 Review.
Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Eugène T, Pallardy A, Frampas E, Carlier T, Ferrer L, Gaschet J, Davodeau F, Gestin JF, Faivre-Chauvet A, Barbet J, Chérel M. Kraeber-Bodéré F, et al. Among authors: bodet milin c. Semin Oncol. 2014 Oct;41(5):613-22. doi: 10.1053/j.seminoncol.2014.07.004. Epub 2014 Jul 22. Semin Oncol. 2014. PMID: 25440606 Review.
Immuno-PET for Clinical Theranostic Approaches.
Bailly C, Cléry PF, Faivre-Chauvet A, Bourgeois M, Guérard F, Haddad F, Barbet J, Chérel M, Kraeber-Bodéré F, Carlier T, Bodet-Milin C. Bailly C, et al. Among authors: bodet milin c. Int J Mol Sci. 2016 Dec 28;18(1):57. doi: 10.3390/ijms18010057. Int J Mol Sci. 2016. PMID: 28036044 Free PMC article. Review.
Tumor immunotargeting using innovative radionuclides.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Mathieu C, Guérard F, Frampas E, Carlier T, Chouin N, Haddad F, Chatal JF, Faivre-Chauvet A, Chérel M, Barbet J. Kraeber-Bodéré F, et al. Among authors: bodet milin c. Int J Mol Sci. 2015 Feb 11;16(2):3932-54. doi: 10.3390/ijms16023932. Int J Mol Sci. 2015. PMID: 25679452 Free PMC article. Review.
Radioimmunotherapy for Treatment of Acute Leukemia.
Bodet-Milin C, Kraeber-Bodéré F, Eugène T, Guérard F, Gaschet J, Bailly C, Mougin M, Bourgeois M, Faivre-Chauvet A, Chérel M, Chevallier P. Bodet-Milin C, et al. Semin Nucl Med. 2016 Mar;46(2):135-46. doi: 10.1053/j.semnuclmed.2015.10.007. Semin Nucl Med. 2016. PMID: 26897718 Review.
Interest of Pet Imaging in Multiple Myeloma.
Jamet B, Bailly C, Carlier T, Touzeau C, Nanni C, Zamagni E, Barré L, Michaud AV, Chérel M, Moreau P, Bodet-Milin C, Kraeber-Bodéré F. Jamet B, et al. Among authors: bodet milin c. Front Med (Lausanne). 2019 Apr 9;6:69. doi: 10.3389/fmed.2019.00069. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31024917 Free PMC article. Review.
106 results